O'Neill Gilmore Neil Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$898,657.79

Insider Activity of O'Neill Gilmore Neil

According to the SEC Form 4 filings, O'Neill Gilmore Neil, being in a position of

  1. CEO at Editas Medicine, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 31501 share for $80,064,
    over all time since 2023-06-05, has bought 0 shares, and sold 168591 share for $1.02M.

Biography of O'Neill Gilmore Neil

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $80,0644100

Comparison of Insiders on Amount of Buys and Sells

2026-09-03SaleEditas Medicine, Inc.
EDIT
CEO
5,124
0.0033%
$3.04$15,563-13.64%
2026-06-03SaleEditas Medicine, Inc.
EDIT
CEO
15,380
0.0153%
$2.70$41,543-0.54%
2026-03-03SaleEditas Medicine, Inc.
EDIT
CEO
5,394
0.0052%
$2.02$10,894+35.78%
2025-12-03SaleEditas Medicine, Inc.
EDIT
CEO
5,603
0.006%
$2.15$12,064+11.81%
2025-09-03SaleEditas Medicine, Inc.
EDIT
CEO
5,592
0.0065%
$2.60$14,517+8.2%
2025-06-03SaleEditas Medicine, Inc.
EDIT
CEO
15,192
0.0172%
$1.72$26,196+40.66%
2025-03-04SaleEditas Medicine, Inc.
EDIT
CEO
16,632
0.0193%
$1.71$28,452+25.57%
2024-12-03SaleEditas Medicine, Inc.
EDIT
CEO
1,618
0.0021%
$2.08$3,361+5.05%
2024-09-04SaleEditas Medicine, Inc.
EDIT
CEO
1,555
0.0018%
$3.42$5,325-41.29%
2024-06-04SaleEditas Medicine, Inc.
EDIT
CEO
12,191
0.0142%
$5.50$66,997-61.65%
2024-03-05SaleEditas Medicine, Inc.
EDIT
CEO
77,824
0.0981%
$9.42$732,884-58.59%
2023-06-05SaleEditas Medicine, Inc.
EDIT
CEO
6,486
0.0095%
$9.50$61,638-12.76%
Total: 12
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.